CXLD: Vitamin D Optimizaton for Workforce Health, Productivity, Safety, and Value Creation
Monday, April 28, 2025
10:30 AM – 11:30 AM CT
Vitamine D deficiency, insufficiency, and sub-optimal levels are common in modern populations and in modern workforces, which increasingly suffer from decreased sun exposure due to indoor work. Inadequate vitamin D increases population cancer, heart disease, auto-immune disease, Alzheimer's disease, depression, anxiety, infection, diabetes, asthma, bone disease, dental disease, reproductive problems, IQ decline, premature delivery, and accelerated aging. Vitamin D pathophysiology knowledge has increased dramatically in the last 15 years, but clinical practice has not incorporated this very high-value preventive tool. The modern details of vitamin D physiology will be reviewed. The impact on many important systems modulated by vitamin D (1000 genes controlled) will be reviewed. The safety, costs, methods, and both health and economic benefits of a workforce program to optimize workforce vitamin D will be reviewed, including the estimated increase in revenue resulting from vitamin D full sufficiency via improvements of workforce morale and health-related productivity.
Learning Objectives:
Justify to corporate decision makers the high value of optimal workforce vitamin D sufficiency.
Explain the large individual variability of vitamin D metabolism and the importance of serum testing of vitamin D levels to guide supplement doseage, thus addressing health equity in the workforce.
Summarize the conflicting literature about vitamin D sufficiency and so to justify vitamin D measurement and supplementation to 50 ng/ml in most populations, despited outdated screening and supplementation standards.
Disclosure(s):
George Anstadt, MD: No financial relationships to disclose
Sunil J. Wimalawansa, MD PhD DSc MBA FRCPath: No financial relationships to disclose